Pyc Therapeutics Ltd has released a press release.
Conclusion of Genentech Antimicrobial Collaboration
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Earlier from PYC Therapeutics
- Retail Offer Document
- PYCs Institutional Entitlement Offer Closes
- Entitlement Offer - Investor Presentation
- $26.8m Fully Underwritten Accelerated Entitlement Offer
- Sept 2019 Quarterly Shareholder Update and Appendix 4C
Later from PYC Therapeutics
- Drug Delivery Greater Than 100% More Effective In Animals
- Quarterly Shareholder Update
- Appendix 4C - quarterly
- Expansion Of Drug Development Pipeline
- CEO Appointment and Establishment of US Office
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics